These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8313596)

  • 1. Solid-phase extraction combined with radioimmunoassay for measurement of zalcitabine (2',3'-dideoxycytidine) in plasma and serum.
    Roberts WL; Buckley TJ; Rainey PM; Jatlow PI
    Clin Chem; 1994 Feb; 40(2):211-5. PubMed ID: 8313596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved combined solid-phase extraction-RIA method for quantifying zalcitabine in plasma.
    Kastrissios H; Nakano M; Burton P; Blaschke T
    Clin Chem; 1996 Mar; 42(3):465-6. PubMed ID: 8598115
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluid.
    Burger DM; Rosing H; ten Napel CH; Duyts T; Meenhorst PL; Mulder JW; Koks CH; Bult A; Beijnen JH
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2763-7. PubMed ID: 7695259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum.
    Harker AJ; Evans GL; Hawley AE; Morris DM
    J Chromatogr B Biomed Appl; 1994 Jul; 657(1):227-32. PubMed ID: 7952073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermospray liquid chromatographic-mass spectrometric analysis of anti-AIDS nucleosides: quantification of 2',3'-dideoxycytidine in plasma samples.
    Jajoo HK; Bennett SM; Kornhauser DM
    J Chromatogr; 1992 Jun; 577(2):299-304. PubMed ID: 1328268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism and rate of placental transfer of zalcitabine (2',3'-dideoxycytidine) in Macaca nemestrina.
    Tuntland T; Nosbisch C; Baughman WL; Massarella J; Unadkat JD
    Am J Obstet Gynecol; 1996 Mar; 174(3):856-63. PubMed ID: 8633656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders.
    Klecker RW; Collins JM; Yarchoan RC; Thomas R; McAtee N; Broder S; Myers CE
    J Clin Pharmacol; 1988 Sep; 28(9):837-42. PubMed ID: 2852679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zalcitabine.
    Shelton MJ; O'Donnell AM; Morse GD
    Ann Pharmacother; 1993 Apr; 27(4):480-9. PubMed ID: 8097417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I evaluation of zalcitabine administered to human immunodeficiency virus-infected children.
    Chadwick EG; Nazareno LA; Nieuwenhuis TJ; Massarella JW; de Dennis SR; Williams K; Yogev R
    J Infect Dis; 1995 Dec; 172(6):1475-9. PubMed ID: 7594705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, 3'-fluoro-3'-deoxythymidine and 2',3'-dideoxyinosine in biological samples by high-performance liquid chromatography.
    Frijus-Plessen N; Michaelis HC; Foth H; Kahl GF
    J Chromatogr; 1990 Dec; 534():101-7. PubMed ID: 1965595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of 2',3'-dideoxycytidine in maternal plasma, amniotic fluid, placental and fetal tissues by high-performance liquid chromatography.
    Ding Y; Williamson LN; White CA; Bartlett MG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(2):183-9. PubMed ID: 15522719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of 2',3'-dideoxycytidine: an inhibitor of human immunodeficiency virus.
    Broder S
    Am J Med; 1990 May; 88(5B):2S-7S. PubMed ID: 1692446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New, in Austria registered specialty drugs. Hivid (2',3'-dideoxycytidine; ddC)].
    Töglhofer W
    Wien Klin Wochenschr; 1992; 104(12):363-7. PubMed ID: 1353278
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of drug interactions with anti-human immunodeficiency virus drugs. V. Effect of soluble CD4 on 2',3'-dideoxycytidine kinetics in monkeys.
    Qian M; Swagler AR; Fong KL; Crysler CS; Mehta M; Gallo JM
    Drug Metab Dispos; 1992; 20(3):396-401. PubMed ID: 1355714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of the antiviral nucleoside analogs 3'-azido-3'-deoxythymidine and 2',3'-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes.
    Yao SY; Cass CE; Young JD
    Mol Pharmacol; 1996 Aug; 50(2):388-93. PubMed ID: 8700147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.
    Stretcher BN
    Clin Pharmacokinet; 1995 Jul; 29(1):46-65. PubMed ID: 7586898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiviral activity of dideoxycytidine.
    Jeffries DJ
    J Antimicrob Chemother; 1989 Jan; 23 Suppl A():29-34. PubMed ID: 2541126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.
    Blaney SM; Daniel MJ; Harker AJ; Godwin K; Balis FM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2779-82. PubMed ID: 8593019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and sensitive determination of zidovudine and zidovudine glucuronide in human plasma by ion-pair high-performance liquid chromatography.
    Nadal T; Ortuño J; Pascual JA
    J Chromatogr A; 1996 Jan; 721(1):127-37. PubMed ID: 8653195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the antiviral agent beta-D-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys.
    Ma L; Hurwitz SJ; Shi J; Mcatee JJ; Liotta DC; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 1999 Feb; 43(2):381-4. PubMed ID: 9925539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.